Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...

How Does Tzield Work in Type 1 Diabetes? Type 1 diabetes is an autoimmune disease in which your immune system mistakenly attacks and damages the beta cells in your pancreas. The beta cells produce ...

Screening children for type 1 diabetes-associated islet autoantibodies at ages 2 years and 6 years would identify most of those who go on to develop the condition by mid-adolescence, new data suggest.

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Obesity drugs were first approved to treat type ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to large-scale health studies, to identify adults who could benefit from new drugs, ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

A team of engineers and biologists has wired flexible electronics directly into lab-grown pancreatic cell clusters, creating hybrid structures that can be monitored and electrically stimulated for ...

While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).